APA (7th ed.) Citation

Giovannoni, G., Soelberg Sorensen, P., Cook, S., Rammohan, K. W., Rieckmann, P., Comi, G., . . . Vermersch, P. (2019). Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study. Multiple sclerosis, 25(6), 819. https://doi.org/10.1177/1352458518771875

Chicago Style (17th ed.) Citation

Giovannoni, Gavin, Per Soelberg Sorensen, Stuart Cook, Kottil W. Rammohan, Peter Rieckmann, Giancarlo Comi, Fernando Dangond, Christine Hicking, and Patrick Vermersch. "Efficacy of Cladribine Tablets in High Disease Activity Subgroups of Patients with Relapsing Multiple Sclerosis: A Post Hoc Analysis of the CLARITY Study." Multiple Sclerosis 25, no. 6 (2019): 819. https://doi.org/10.1177/1352458518771875.

MLA (9th ed.) Citation

Giovannoni, Gavin, et al. "Efficacy of Cladribine Tablets in High Disease Activity Subgroups of Patients with Relapsing Multiple Sclerosis: A Post Hoc Analysis of the CLARITY Study." Multiple Sclerosis, vol. 25, no. 6, 2019, p. 819, https://doi.org/10.1177/1352458518771875.